Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies
Aleksandra Szczęsnowicz, Anna Szeliga, Olga Niwczyk, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5915-5915
Open Access | Times Cited: 24

Showing 24 citing articles:

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
Zhuo Liu, Rui‐Han Wang, Kehua Wang
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 2
Incretin Hormone Secretion in Women with Polycystic Ovary Syndrome: Roles of Obesity, Insulin Sensitivity and Treatment with Metformin and GLP-1s
Andrea Etrusco, Mislav Mikuš, Antonio D’Amato, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 653-653
Open Access | Times Cited: 9
Glucagon-like Peptide-1 Receptor Agonists: Exciting Avenues Beyond Weight Loss
Lalitha Sundararaman, Divakara Gouda, Anil Kumar, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1978-1978
Open Access | Times Cited: 1
Clinical manifestations of polycystic ovary syndrome
Radmila Sparić, Jelena Zlatar, Luka Nikolić, et al.
Medicinska istrazivanja (2024) Vol. 57, Iss. 4, pp. 93-102
Closed Access | Times Cited: 7
Scientific Progress in Polycystic Ovary Syndrome: Little by Little
Johannes Ott, Marlene Hager
Journal of Clinical Medicine (2025) Vol. 14, Iss. 1, pp. 200-200
Open Access
The last update on polycystic ovary syndrome(PCOS), diagnosis criteria, and novel treatment
Arghavan Ghafari, Malihe Maftoohi, Mohammadamin Eslami Samarin, et al.
Endocrine and Metabolic Science (2025), pp. 100228-100228
Open Access
GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity
Margaret A. Stefater‐Richards, Grace Jhe, Yanjia J. Zhang
PEDIATRICS (2025)
Closed Access
The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications—A Narrative Review
Jasmin Mahabamunuge, Nicole M. Sekula, Christina Lepore, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 709-709
Open Access
Comparison of Metformin and Metformin Plus Liraglutide for Treating Metabolic Syndrome in Patients with Polycystic Ovarian Syndrome (PCOS)
Yousra Naz, Zeryab Setna, Sabiha Banu, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 3, pp. 238-243
Closed Access
Comprehensive overview of polycystic ovary syndrome: Pathophysiology, clinical features, and emerging therapeutic approaches
Larsa Naji Adam, Lina N. Adam
Obesity Medicine (2025) Vol. 55, pp. 100606-100606
Closed Access
GLP-1 receptor agonists efficacy in managing comorbidities associated with diabetes mellitus: a narrative review
Mahdi Gholami, Narges Zargar Balajam, Samira Rakhsha, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Effects of Exenatide plus Metformin versus Metformin alone on insulin resistance in women with Polycystic Ovary Syndrome: A systematic review and meta‐analysis
Abd‐alrahman Al‐Qudah, Mohammad Al‐Hanaktah, Reham Albadaineh
Journal of Obstetrics and Gynaecology Research (2025) Vol. 51, Iss. 5
Closed Access
Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review
Melissa Frangie Machado, Taylor Shunk, Grace Hansen, et al.
Cureus (2024)
Open Access | Times Cited: 1
The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment
Sotirios Pililis, Stamatios Lampsas, Aikaterini Kountouri, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1656-1656
Open Access | Times Cited: 1
Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study
Roger S. McIntyre, Angela T.H. Kwan
Expert Opinion on Drug Safety (2024), pp. 1-6
Closed Access | Times Cited: 1
Impact of Dramatic Weight Loss with the New Injectable Medications on
Zaher Merhi
F&S Reports (2024)
Open Access | Times Cited: 1
current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
Justyna Lipińska, Maria Kowalczuk, Łukasz Lipiński, et al.
Journal of Education Health and Sport (2024) Vol. 59, pp. 166-182
Open Access
Efficacy and safety of glucagon-like peptide-1 receptor agonists in the treatment of polycystic ovary syndrome-A systematic review and meta-analysis
Xin Tong, Xiaoxuan Song, Yingshi Zhang, et al.
Archives of Physiology and Biochemistry (2024), pp. 1-7
Closed Access
Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS
Aleksandra Jaroń, Agata Wiklińska, Katarzyna Jastrzębska, et al.
Quality in Sport (2024) Vol. 20, pp. 53831-53831
Open Access
GLP-1 Medications in the Social Media Spotlight: Content Analysis of Women's Health, Nontraditional Access, and Barriers to Access (Preprint)
Brittnie E. Bloom, Marie A. Bragg, Melanie Jay, et al.
(2024)
Closed Access
Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes
Lidiya Kukova, Kashif M. Munir, Sayeed Ahmed, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 10, pp. 939-952
Closed Access
Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
Gabriela D Briceño Silva, Karem D Thomas Garcia, Hrachya Ajamyan, et al.
Cureus (2024)
Open Access
Exploring the Therapeutic Potential of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Polycystic Ovary Syndrome
Miis Akel, Aya Ziq, Paul Kaldas, et al.
Cureus (2024)
Open Access
Glucagon-like Peptide 1 Receptor Agonists and Obesity Associated with Eating Disorders
Riccardo Dalle Grave
IJEDO (2024) Vol. 6, pp. 15-24
Open Access
Glucagon-Like Peptide-1 Receptor Agonist Mediated Weight Loss and Diabetes Mellitus Benefits: A Narrative Review
Alan D. Kaye, Nathan Lien, Christopher Vuong, et al.
Cureus (2024)
Open Access
Page 1

Scroll to top